STING1 and neoplasm: Tumor cells undergoing ICD secrete type I IFNs through the activation of TLR3 by cyclic guanosine monophosphate-adenosine monophosphate synthase/stimulator of interferon genes (cGAS/STING) signaling pathway (62).